About the IOV
The Veneto Institute of Oncology IOV – IRCCS is the first and only medical center in the Veneto region specific for the prevention, diagnosis and treatment of cancer and for cancer research.
The IOV has been established by the Veneto Regional Government in December 2005, becoming a highly specialized health research center of national and international importance.
It is recognized by the Ministry of Health as a research hospital (IRCCS) and by the Organization of European Cancer Institutes (OECI) as a Comprehensive Cancer Center. It is a member of the network of excellence Alliance Against Cancer (ACC), the largest Italian organization of clinical and translational cancer research.
Scientific research integrated into clinical care is the characteristic that substantially differentiates the IOV from other healthcare companies without the IRCCS qualification. The IOV, in addition to being subject to the control system of the Veneto Region, undergoes, a two-year verification process by the Ministry of Health to confirm the IRCCS status for cancer care and research and an annual verification of scientific research results, which is linked to the funding of current research activities.
Over the years, the IOV – IRCCS has consistently earned increased ministerial funding, which rewards parameters such as scientific productivity, clinical trials and quality of care. In 2017, in particular, the contribution to Current Research approached 4 million euros (3.904.567,06) after having exceeded 3 million euros (3,195,361.35) for the first time just two years before. This trend places the IOV at the top level of national scientific productivity, especially in terms of the number of researchers employed.
The integration of research and clinical care guarantees the provision of diagnostic and treatment services according to standards of excellence, both in ordinary hospitalization, including day hospital and day surgery, and outpatient procedures. To provide these services, IOV – IRCCS employs avant-garde diagnostic-therapeutic pathways (PDTA), in line with standards recognized at the European level and as indicated by regional provisions, based on a multidisciplinary approach to cancer, which focuses on the person and the quality of his or her life. The IOV carries out its activities in agreement with the City Hospital of Padua, Local Health Unit “no. 6 Euganea” and the University of Padua.
The diagnostic-therapeutic pathways (PDTA) are set up within the Veneto Oncology Network (ROV). The Veneto Region has designated the IOV – IRCCS as the head of the Regional Coordination of the ROV and the hub of the ROV, in strict harmony with the Hospital Companies of Padua and Verona. In this sense, the IOV is the fulcrum of the Veneto regional network of Breast Unit centers.
The Veneto Oncological Institute is based in Padua, Italy, at the Busonera Hospital. Other sites in Padua include the Radiotherapy Building, in the Hospital area, and Palazzo Santo Stefano, in the center of town, with offices of the Scientific Directorate, the Administrative Directorate and some staff services. The IOV also has a branch office, clinics and surgical department at the San Giacomo Hospital in Castelfranco Veneto (TV) and a Radiotherapy clinic at the Ospedali Riuniti Padova Sud in Schiavonia (Monselice, PD).
Volume of activity 2017: Health services
Volume of activity
|Chemotherapy treatments (infusion therapies only)||
|Discharge from ordinary hospitalization||
|Discharge from day hospitalization||
|Office Visits (including follow-up)||
|Senological Radiology procedures||
|Radiotherapy procedures (IOV facilities and partner facilities)||
Publications and Impact factor
N ° publications
IF /researcher with publications
* In 2016 the criterion for researcher reporting has changed